Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial

By Klemp J.   Brady D.   Frank T.S.   Kimler B.F.   Fabian C.J.  

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1209-1214

Elsevier

Access to resources Recommend Favorite

Psychological impact of genetic testing in women from high-risk breast cancer families

By Meiser B.   Butow P.   Friedlander M.   Barratt A.   Schnieden V.   Watson M.   Brown J.   Tucker K.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 2025-2031

Elsevier

Access to resources Recommend Favorite

Breast reduction surgery and breast cancer risk: does reduction mammoplasty have a role in primary prevention strategies for women at high risk of breast cancer?

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 235-236

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

By Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer

By                

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 389-393

Spandidos Publications

Access to resources Recommend Favorite